Sinusitis
Sinusitis, also known as rhinosinusitis, is an inflammation of the mucous membranes lining the sinuses, typically caused by fluid buildup from a cold or allergies, leading to symptoms such as thick nasal mucus, facial pressure, fever, nasal congestion, and postnasal drip.
Health Outcomes
- Absence of Serious Adverse Events
- Achieved Complete Symptom Cessation
- Adverse Safety Concern from Antimicrobial Resistance
- Colonization of Nasopharynx or Adenoid Tissue
- Enhanced Innate Immune Function
- Enhanced Mucosal Immune Function
- Enhanced Resistance to Infections
- Enhanced Resistance to Respiratory Infections
- Improved Antibacterial Activity
- Improved Antibiotic Sensitivity
- Improved Antimicrobial Ability
- Improved Control of Otitis Media
- Improved Disease Resolution
- Improved Health Outcome Relative to Zinc Bacitracin
- Improved Immune Mechanisms Against S. pneumoniae
- Improved Mucosal Immunity
- Improved Nasal Histopathology
- Improved Nasal Mucosa Histology
- Improved Nasal Symptoms in Perennial Allergic Rhinitis
- Improved Quality of Life for Eye, Nose, and Throat Symptoms
- Improved Self-reported Halitosis Score
- Increased Antibiotic Susceptibility
- Increased Antibiotic Use
- Increased Days Without Illness
- Increased Dispersal of Pathogenic Bacteria
- Increased Economic Burden Due to Higher Antibiotic Costs
- Increased Incidence of Upper Respiratory Symptoms
- Increased Incidence of Upper Respiratory Tract Infections
- Increased Mucin Secretion
- Increased Mucus Secretion
- Increased Neutrophil Activity
- Increased Skin Mucus Protein Levels
- Increased URTI-Free Rate
- Inhibition of Harmful Bacterial Growth
- Modulated Upper Airway Immune Response
- Nasopharyngeal Colonization
- No Adverse Morphometric Parameter Effects
- No Reduction in Antibiotic Use
- Persistent Nasal Colonization
- Potentially Effective Antibacterial Proteins
- Prevented Upper Respiratory Tract Infection
- Prevention of Mucus Barrier Decline
- Reduced Antibiotic Duration
- Reduced Antibiotic Usage
- Reduced Antibiotic Use
- Reduced Antibiotic Use Due to Infections
- Reduced Antibiotic and Antiviral Use
- Reduced Bacterial Infection Severity
- Reduced Bacterial Load
- Reduced Beta-Lactam Resistance
- Reduced Bloody Nasal Mucus
- Reduced Day Care Absenteeism Due to Infections
- Reduced Days on Antibiotic Therapy
- Reduced Days with Runny Nose Symptoms
- Reduced Disruption of Normal Activities Due to Allergies
- Reduced Duration of Acute Respiratory Infection
- Reduced Duration of Antibiotic Usage
- Reduced Duration of Nasal Symptoms
- Reduced Duration of Respiratory Tract Infection Episode
- Reduced Duration of Respiratory Tract Infections
- Reduced Duration of URTI-Associated Symptoms
- Reduced Exacerbation of Chronic Adenoiditis
- Reduced Halitosis
- Reduced IL-5 Levels
- Reduced Incidence Rate of URTIs
- Reduced Incidence of Common Infections
- Reduced Incidence of Side Infections during Antibiotic Treatments
- Reduced Incidence of Streptococcal Pharyngitis
- Reduced Incidence of Upper Respiratory Tract Infections
- Reduced Infection Recurrence
- Reduced Localized Infection
- Reduced Mean Number of Infections per Child
- Reduced Medication Use for Allergies
- Reduced Mold Presence
- Reduced Mucosal Inflammation
- Reduced Mucus Secretion
- Reduced Nasal Colonization
- Reduced Nasal Congestion
- Reduced Nasal Inflammation
- Reduced Nasal Mucosa Neutrophil Infiltration
- Reduced Nasal Stuffiness
- Reduced Nasal Symptom Score
- Reduced Nasal Symptoms
- Reduced Otitis Media Episode Incidence
- Reduced Pathogenic Bacteria
- Reduced Pathogenic Bacteria Load
- Reduced Pathogenic Bacterial Activity
- Reduced Pathogenic Bacterial Populations
- Reduced Pathogenic Colonies
- Reduced Respiratory Symptom Days
- Reduced Respiratory Symptoms
- Reduced Rhinitis
- Reduced Risk of Antimicrobial Resistance
- Reduced Severity of Allergic Rhinitis Symptoms
- Reduced Severity of Nasal Congestion and Runny Nose
- Reduced Severity of URTIs
- Reduced Sick Leave Days
- Reduced Sinusitis Severity
- Reduced Sneezing Symptoms
- Reduced Total Nasal Symptom Score
- Reduced URTI Symptoms
- Reduced Upper Respiratory Infections
- Reduced Upper Respiratory Symptoms
- Reduced Upper Respiratory Tract Infection
- Reduced Upper Respiratory Tract Infection Days
- Reduced Upper Respiratory Tract Infection Duration
- Reduced Upper Respiratory Tract Infection Severity
- Reduced Upper Respiratory Tract Infection Symptoms
- Reduced Upper Respiratory Tract Infection Treatment Duration
- Reduced Use of URTI-Associated Medication
- Restored Goblet Cell Function
- Restored Microbial Community Structure in Upper Respiratory Tract
- Shortened Treatment Course
- Unchanged Inflammatory Response
- Unchanged Severity of URTI
- Upper Respiratory Tract Colonization